Select Country

Select a country to view information on local trademark law


Countries
A-E  F-J  K-O  P-T  U-Z

Multinational Agreements
EUIPO  WIPO
AIPO/OAPI  ARIPO
SEARCH
TRADEMARKS
FOR FREE
+
+
TMZOOM

Get Listed

Promote your expertise to IP professionals worldwide.
read more

Show Articles

Subscribe to Free Newsletter

To keep updated on the latest amendments to international trademark laws click here

Amendments to Trademark Laws

Print this page
Mai 29, 2012 (Newsletter Issue 9/12)
India
Show Country Survey

First Compulsory License


In a much-awaited decision the Indian Patent Office issued its first compulsory licensing order relating to generic drugs.

On March 9, 2012, the Indian Patent Office allowed Natco Pharma Ltd, an Indian generic drug manufacturer to manufacture and sell generic version of a blockbuster cancer drug patented by the German Bayer Corp, thus invoking the compulsory license provisions of the Patents Act. The Patent Controller held that the the drug was exorbitantly priced, which conflicts with public requirements because the medicine was not affordable for many of them. While granting the compulsory license to Natco, the Patent Controller imposed certain conditions. This included that the price of the drug shall not exceed a certain amount for a month’s treatment, and that the licence is non-exclusive and non-assignable. In addition, Natco must pay royalty on net sales, manufacture on its own and sell only in India, and supply the drug free of cost to a certain amount of needy and deserving patients each year. Bayer has appealed against the order before Intellectual Property Appellate Board (IPAB).

Source: Lex Orbis IP Practice, India